Month: February 2023
Cabozantinib as active treatment in second line advanced/metastatic clear cell Renal cell cancer
The results of the Cabopoint study presented at GU ASCO 2023 indicated that cabozantinib could be a promising second-line treatment option for patients with renal…
NeoAdjuvant Immunotherapy and Chemotherapy in Lung Cancer showed promising results
The Neoadjuvant chemotherapy and immunotherapy are showing promising results in management of Non-small cell lung cancer. Neoadjuvant chemotherapy involves administering chemotherapy drugs before surgery to…